Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-box 20 pseudogene is a non-coding genomic element showing very high sequence homology (98.4%) to parts of the protein-coding gene T-box 20 (*TBX20*), specifically covering exons 5 and 6, and located on human chromosome 12[1]. Pseudogenes do not encode functional proteins and generally do not have established biological functions or direct disease associations. TBX20 itself is a T-box family transcription factor essential for cardiac development, but the pseudogene does not share these functions or roles[1][4][7]. Pseudogene expression has been explored as a marker in some cancer classification studies, but there is no evidence that this specific pseudogene has clinical or therapeutic utility[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-box 20 pseudogene.